No Data
No Data
No Data
No Data
No Data
Fu'an Pharmaceutical (300194.SZ): Qingyutang received drug registration certificates for pentazocin injections and midazolam injections
On April 30, Gelonghui Pharmaceutical (300194.SZ) announced that Fu'an Pharmaceutical Group Qingyutang Pharmaceutical Co., Ltd. (“Qingyutang”), a wholly-owned subsidiary of the company, recently received a drug registration certificate issued by the State Drug Administration. The related drugs are pentazocin injection and midazolam injection, respectively. Pentazocine injection is suitable for all kinds of severe chronic pain, such as cancerous pain, traumatic pain, and pain after surgery. It can also be used for administration before surgery or before anesthesia, as an adjuvant to surgical anesthesia. Up to now, 2 companies (including Qingyutang) have passed the consistency evaluation or been deemed to have passed the drug
Gelonghui FinanceApr 30 06:58 ET
Fuan Pharmaceutical (300194.SZ) announced its 2023 annual results, with net profit of 232 million yuan, an increase of 13.32%
Fuan Pharmaceutical (300194.SZ) released its 2023 annual report. During the reporting period, the company achieved operating income of 2...
Zhitong FinanceApr 24 05:09 ET
Fuan Pharmaceutical (300194.SZ): Midazolam hydrochloride obtained approval notice for the marketing application of chemical raw materials
Fuan Pharmaceutical (300194.SZ) announced that Fuan Pharmaceutical Group Chongqing Bosheng Pharmaceutical Co., Ltd., a wholly-owned subsidiary of the company...
Zhitong FinanceApr 9 07:58 ET
Fuan Pharmaceutical (300194.SZ): Nimergoline tablets received a drug registration certificate
Gelonghui, April 7 | Fu'an Pharmaceutical (300194.SZ) announced that its wholly-owned subsidiary Fu'an Pharmaceutical Group Qingyutang Pharmaceutical Co., Ltd. recently received a drug registration certificate issued by the State Drug Administration. Drug name: nimegoline tablets. Nimergoline tablets are suitable for improving low motivation due to the sequelae of a stroke; they are also suitable for vascular dementia. In particular, during early treatment, they improve cognition, memory, etc., and can reduce the severity of the disease.
Gelonghui FinanceApr 7 05:13 ET
Fuan Pharmaceutical (300194.SZ): Does not produce radiation protection drugs
Gelonghui, March 28 | Fuan Pharmaceutical (300194.SZ) said on the investor interactive platform that the company currently does not produce radiation-proof drugs, and that the company will keep an eye on diseases and radiation lesions that may be caused to humans by draining nuclear sewage into the sea.
Gelonghui FinanceMar 28 03:30 ET
Fuan Pharmaceutical (300194.SZ): Currently not producing diet drugs
Gelonghui March 11 丨 An investor asked Fuan Pharmaceutical (300194.SZ) on the investor interactive platform, “How is the negotiation process for the company to introduce the production of diet pills to Lilai?” The company replied that the company currently does not produce diet drugs.
Gelonghui FinanceMar 11 04:18 ET
No Data
No Data